Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD

Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom

(2022) Chanjira Satukijchai et al.   JAMA Network Open

Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria

(2022) Giulia Fadda et al.   Multiple Sclerosis Journal

Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease

(2022) Alessandro Dinoto et al.   Frontiers in Neurology

Pure Relapsing Short Myelitis

(2022) Zélia Poullet et al.   Neurology-Neuroimmunology & Neuroinflammation

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management

(2022) Elia Sechi et al.   Frontiers in Neurology

The long‐term outcome of MOGAD: An observational national cohort study of 61 patients

(2021) Romain Deschamps et al.   EUROPEAN JOURNAL OF NEUROLOGY

Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care

(2021) Giulia Fadda et al.   LANCET NEUROLOGY

Discontinuation of Immunosuppressive Therapy in Patients With Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies

(2021) Su-Hyun Kim et al.   Neurology-Neuroimmunology & Neuroinflammation

Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder

(2021) Ilya Ayzenberg et al.   Neurology-Neuroimmunology & Neuroinflammation

Myelin-oligodendrocyte glycoprotein antibody-associated disease

(2021) Romain Marignier et al.   LANCET NEUROLOGY

CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies

(2021) Hannah H. Zhao-Fleming et al.   NEUROLOGY

Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders

(2021) Elia Sechi et al.   NEUROLOGY

MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis

(2021) Laura Clarke et al.   Frontiers in Neurology

Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis

(2021) Antje Bischof et al.   ANNALS OF NEUROLOGY

Relapse activity in the chronic phase of anti-myelin-oligodendrocyte glycoprotein antibody-associated disease

(2021) Tetsuya Akaishi et al.   JOURNAL OF NEUROLOGY

Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders

(2021) Valentina Camera et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Age at onset predicts outcome in aquaporin-4-IgG positive neuromyelitis optica spectrum disorder from a United Kingdom population

(2021) Athanasios Papathanasiou et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Brighter spotty lesions on spinal MRI help differentiate AQP4 antibody-positive NMOSD from MOGAD

(2021) Jae-Won Hyun et al.   Multiple Sclerosis Journal

Evaluation and Management of Acute Myelopathy

(2021) Elia Sechi et al.   SEMINARS IN NEUROLOGY

Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder

(2021) Valentina Camera et al.   JAMA Network Open

Comparison of Spinal Cord Magnetic Resonance Imaging Features Among Children With Acquired Demyelinating Syndromes

(2021) Giulia Fadda et al.   JAMA Network Open

Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies

(2020) Elia Sechi et al.   Multiple Sclerosis Journal

Diagnostic value of bright spotty lesions on MRI after a first episode of acute myelopathy

(2020) Sylvain Rabasté et al.   JOURNAL OF NEURORADIOLOGY

Clinical and MRI phenotypes of sarcoidosis-associated myelopathy

(2020) Olwen C. Murphy et al.   Neurology-Neuroimmunology & Neuroinflammation

Onset of progressive motor impairment in patients with critical central nervous system demyelinating lesions

(2020) Roman M Kassa et al.   Multiple Sclerosis Journal

Critical spinal cord lesions associate with secondary progressive motor impairment in long-standing MS: A population-based case-control study

(2020) Elia Sechi et al.   Multiple Sclerosis Journal

Spinal Cord Atrophy in Neuromyelitis Optica Spectrum Disorders Is Spatially Related to Cord Lesions and Disability

(2020) Laura Cacciaguerra et al.   RADIOLOGY

Value of Area Postrema Syndrome in Differentiating Adults With AQP4 vs. MOG Antibodies

(2020) Jae-Won Hyun et al.   Frontiers in Neurology

Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

(2020) Alvaro Cobo‐Calvo et al.   ANNALS OF NEUROLOGY

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients

(2020) Sven Jarius et al.   Journal of Neuroinflammation

Inflammatory activity following motor progression due to critical CNS demyelinating lesions

(2020) Shreya Nayak et al.   Multiple Sclerosis Journal

Long-term Outcomes in Patients With Myelin Oligodendrocyte Glycoprotein Immunoglobulin G–Associated Disorder

(2020) Sebastian Lopez-Chiriboga et al.   JAMA Neurology

Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis

(2020) Romina Mariano et al.   BRAIN

Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors

(2020) Pietro Iaffaldano et al.   Multiple Sclerosis Journal

Variability of cerebrospinal fluid findings by attack phenotype in myelin oligodendrocyte glycoprotein-IgG-associated disorder

(2020) Elia Sechi et al.   Multiple Sclerosis and Related Disorders

Clinical and transcriptional recovery profiles in pediatric and adult multiple sclerosis patients

(2020) Shay Menascu et al.   Annals of Clinical and Translational Neurology

Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders

(2020) Simon Rinaldi et al.   Neurology-Neuroimmunology & Neuroinflammation

Progression pattern of neurological disability with respect to clinical attacks in anti-MOG antibody-associated disorders

(2020) Tetsuya Akaishi et al.   JOURNAL OF NEUROIMMUNOLOGY

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

(2019) Olga Ciccarelli et al.   LANCET NEUROLOGY

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders

(2019) Jacqueline Palace et al.   BRAIN

The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults

(2019) CL de Mol et al.   Multiple Sclerosis Journal

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines

(2019) Massimo Filippi et al.   BRAIN

Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study

(2019) Jonathan Ciron et al.   Multiple Sclerosis Journal

Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology

(2019) Elia Sechi et al.   NEUROLOGY

Unilateral motor progression in MS

(2019) Elia Sechi et al.   NEUROLOGY

The Cerebrospinal Fluid in Multiple Sclerosis

(2019) Florian Deisenhammer et al.   Frontiers in Immunology

Seroprevalence and clinical phenotype of MOG-IgG-associated disorders in Sri Lanka

(2019) Bimsara Senanayake et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

McArdle Sign: A Specific Sign of Multiple Sclerosis

(2019) Filippo Savoldi et al.   MAYO CLINIC PROCEEDINGS

Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes

(2019) Patrick Waters et al.   JAMA Neurology

Does area postrema syndrome occur in myelin oligodendrocyte glycoprotein-IgG–associated disorders (MOGAD)?

(2019) Amy Kunchok et al.   NEUROLOGY

The frequency of longitudinally extensive transverse myelitis in MS: A population-based study

(2019) Solmaz Asnafi et al.   Multiple Sclerosis and Related Disorders

Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder

(2019) Amy Kunchok et al.   Multiple Sclerosis and Related Disorders

Relapse recovery

(2019) Orhun H. Kantarci et al.   Neurology-Neuroimmunology & Neuroinflammation

Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis

(2018) Elia Sechi et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

(2018) Alan J Thompson et al.   LANCET NEUROLOGY

Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies

(2018) Hilda Guerra et al.   MAYO CLINIC PROCEEDINGS

Spinal cord volume loss

(2018) Charidimos Tsagkas et al.   NEUROLOGY

Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability

(2018) Paola Valsasina et al.   RADIOLOGY

Novel Glial Targets and Recurrent Longitudinally Extensive Transverse Myelitis

(2018) Jiraporn Jitprapaikulsan et al.   JAMA Neurology

Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG–Associated Disorders

(2018) A. Sebastian López-Chiriboga et al.   JAMA Neurology

Progressive motor impairment from a critically located lesion in highly restricted CNS-demyelinating disease

(2018) B Mark Keegan et al.   Multiple Sclerosis Journal

Age is a critical determinant in recovery from multiple sclerosis relapses

(2018) Brittani L Conway et al.   Multiple Sclerosis Journal

Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity

(2018) Claudia Chien et al.   Multiple Sclerosis Journal

Racial differences in neuromyelitis optica spectrum disorder

(2018) Su-Hyun Kim et al.   NEUROLOGY

Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody

(2018) Divyanshu Dubey et al.   JAMA Neurology

Outcomes from acute attacks of neuromyelitis optica spectrum disorder correlate with severity of attack, age and delay to treatment

(2018) Aditya Banerjee et al.   Multiple Sclerosis and Related Disorders

Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions

(2018) Maureen A. Mealy et al.   Multiple Sclerosis and Related Disorders

Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders

(2017) Mickael Bonnan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response

(2017) Jan-Patrick Stellmann et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings

(2017) Elia Sechi et al.   Multiple Sclerosis Journal

Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses

(2017) Nicholas L. Zalewski et al.   NEUROLOGY

Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings

(2017) Elia Sechi et al.   Multiple Sclerosis Journal

Discriminating long myelitis of neuromyelitis optica from sarcoidosis

(2016) Eoin P. Flanagan et al.   ANNALS OF NEUROLOGY

Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes

(2016) Maria Sepúlveda et al.   JOURNAL OF NEUROLOGY

Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome

(2016) WJ Brownlee et al.   Multiple Sclerosis Journal

Progressive solitary sclerosis

(2016) B. Mark Keegan et al.   NEUROLOGY

Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome

(2016) WJ Brownlee et al.   Multiple Sclerosis Journal

Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome

(2015) Orhun H. Kantarci et al.   ANNALS OF NEUROLOGY

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses

(2015) Ingo Kleiter et al.   ANNALS OF NEUROLOGY

Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis

(2015) C Zecca et al.   Multiple Sclerosis Journal

Multiple sclerosis—a quiet revolution

(2015) Richard M. Ransohoff et al.   Nature Reviews Neurology

Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis

(2015) Martina Novotna et al.   NEUROLOGY

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

(2015) Dean M. Wingerchuk et al.   NEUROLOGY

MRI characteristics of neuromyelitis optica spectrum disorder: An international update

(2015) H. J. Kim et al.   NEUROLOGY

Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis

(2015) Regina Schlaeger et al.   JAMA Neurology

Short Myelitis Lesions in Aquaporin-4-IgG–Positive Neuromyelitis Optica Spectrum Disorders

(2015) Eoin P. Flanagan et al.   JAMA Neurology

Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis

(2015) C Zecca et al.   Multiple Sclerosis Journal

Spinal cord atrophy in multiple sclerosis and relationship with disability across clinical phenotypes

(2015) Evanthia Bernitsas et al.   Multiple Sclerosis and Related Disorders

Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein

(2014) M. Baumann et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Cervical cord lesion load is associated with disability independently from atrophy in MS

(2014) H. Kearney et al.   NEUROLOGY

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies

(2014) Joanna Kitley et al.   JAMA Neurology

Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study

(2013) Nasrin Asgari et al.   BMC Neurology

Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies

(2013) Raffaele Iorio et al.   JOURNAL OF NEUROLOGY

Characterising aggressive multiple sclerosis

(2013) Suresh Menon et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

“Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis

(2013) Tadahiro Yonezu et al.   Multiple Sclerosis Journal

Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica

(2013) Y. Jiao et al.   NEUROLOGY

Aquaporin 4 IgG Serostatus and Outcome in Recurrent Longitudinally Extensive Transverse Myelitis

(2013) Yujuan Jiao et al.   JAMA Neurology

Prognostic Factors of Acute Partial Transverse Myelitis

(2012) Alberto Gajofatto et al.   ARCHIVES OF NEUROLOGY

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

(2012) Sven Jarius et al.   Journal of Neuroinflammation

Neuropathic pruritus (itch) in neuromyelitis optica

(2012) Liene Elsone et al.   Multiple Sclerosis Journal

Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis

(2012) M. H. Sombekke et al.   NEUROLOGY

Solitary sclerosis: Progressive myelopathy from solitary demyelinating lesion

(2012) W. F. Schmalstieg et al.   NEUROLOGY

The differential diagnosis of longitudinally extensive transverse myelitis

(2011) JL Kitley et al.   Multiple Sclerosis Journal

Demographic and clinical characteristics of malignant multiple sclerosis

(2011) T. Gholipour et al.   NEUROLOGY

Paraneoplastic isolated myelopathy: Clinical course and neuroimaging clues

(2011) E. P. Flanagan et al.   NEUROLOGY

Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome

(2011) D. T. Okuda et al.   NEUROLOGY

Spinal Cord Ring Enhancement in Multiple Sclerosis

(2010) Eric C. Klawiter et al.   ARCHIVES OF NEUROLOGY

What is the risk of permanent disability from a multiple sclerosis relapse?

(2010) K. Bejaoui et al.   NEUROLOGY

Astrocytic damage is far more severe than demyelination in NMO: A clinical CSF biomarker study

(2010) R. Takano et al.   NEUROLOGY

Younger children with MS have a distinct CSF inflammatory profile at disease onset

(2010) D. Chabas et al.   NEUROLOGY

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET

Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study

(2008) MA Leone et al.   Multiple Sclerosis Journal